A Double-Blind, Randomized, Parallel Design Study of Aliskiren Versus Hydrochlorothiazide in Mild-to Moderate Hypertensive Type II Diabetes Mellitus Patients on Remodeling of Resistance Arteries
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 20 May 2015
At a glance
- Drugs Aliskiren (Primary) ; Hydrochlorothiazide
- Indications Secondary hypertension
- Focus Therapeutic Use
- 18 May 2015 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 05 Jan 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 01 Dec 2011 New trial record